How have IPIX shares performed in 2024?

Innovation Pharmaceuticals' stock was trading at $0.0049 at the beginning of 2024. Since then, IPIX shares have increased by 106.1% and is now trading at $0.0101. View the best growth stocks for 2024 here .

Are investors shorting Innovation Pharmaceuticals?

Innovation Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 18,000 shares, a drop of 70.4% from the March 15th total of 60,900 shares. Based on an average trading volume of 584,300 shares, the days-to-cover ratio is currently 0.0 days. View Innovation Pharmaceuticals' Short Interest .

What other stocks do shareholders of Innovation Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innovation Pharmaceuticals investors own include Vaxart (VXRT) , Broadcom (AVGO) , Fulcrum Therapeutics (FULC) , VIVUS (VVUS) , CytoDyn (CYDY) , ServiceNow (NOW) , Sorrento Therapeutics (SRNE) , United Airlines (UAL) , Heat Biologics (HTBX) and Micron Technology (MU) .

How do I buy shares of Innovation Pharmaceuticals?

Shares of IPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:IPIX

Innovation Pharmaceuticals (IPIX) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free IPIX Stock Alerts

$0.01

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.01
▼
$0.0194
50-Day Range: $0.0059
▼
$0.0170
52-Week Range: $0.00
▼
$0.02

Volume: 233,533 shs
Average Volume: 768,684 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Innovation Pharmaceuticals alerts:

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

About Innovation Pharmaceuticals Stock (OTCMKTS:IPIX)

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

IPIX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IPIX Stock News Headlines

April 10, 2024 | forbes.com

InnovationRx: $90 Million To Make Drugs In Space

March 25, 2024 | msn.com

India's healthcare innovation market poised to double by 2028

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

February 29, 2024 | msn.com

Pharma company Jubilant Biosys plans to expand India footprint, to foray into new therapeutic areas, says CEO Giuliano Perfetti

January 4, 2024 | msn.com

Healthcare & Pharma Outlook 2024: Companies to focus on quality, sustainability, and accessibility; Surge in R&D expected

December 25, 2023 | msn.com

3 Stocks at the Forefront of Medical Innovation

November 14, 2023 | morningstar.com

Innovation Pharmaceuticals Inc IPIX

November 14, 2023 | morningstar.com

Innovation Pharmaceuticals Inc IPIX

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

November 5, 2023 | msn.com

EU proposal may accelerate pharma innovation decline, industry group says

October 27, 2023 | msn.com

How CPI's latest project will help to digitally transform the pharma industry

September 26, 2023 | msn.com

Pharma Industry Should Prioritise R&D, Focus On Innovative Products: Union Health Minister

August 28, 2023 | finance.yahoo.com

Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024

August 2, 2023 | uk.investing.com

CSPC Innovation Pharmaceutical Co Ltd Class A (300765)

June 21, 2023 | finance.yahoo.com

Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases

June 5, 2023 | finance.yahoo.com

Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing

May 31, 2023 | finance.yahoo.com

IPIX - Innovation Pharmaceuticals Inc.

May 21, 2023 | msn.com

Focus on pharma: Knowledge, drive and FDI has made Ireland a global hub of innovation

May 16, 2023 | msn.com

Prestige Wealth, Innovation Beverage, Scripps Safe slash IPO sizes

April 17, 2023 | finance.yahoo.com

Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications

April 4, 2023 | marketwatch.com

AI in Pharmaceutical Market 2023 Size and Forecast to 2031

April 1, 2023 | wsj.com

CSPC Innovation Pharmaceutical Co. Ltd. A

March 20, 2023 | bizjournals.com

WVU Innovation adds 3 new tenants

March 15, 2023 | finance.yahoo.com

Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers

February 23, 2023 | finance.yahoo.com

Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission

February 17, 2023 | marketwatch.com

Health Supplement Market 2023 : Business Scenario, Corporate Profiles, Size and Dynamic Innovation by 2028

February 17, 2023 | marketwatch.com

Active Pharmaceutical Ingredients Market Report Historical, Current, and Projected Size, in terms of value 2028

See More Headlines

Receive IPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:IPIX
CUSIP: N/A
CIK: 1355250
Web: www.cellceutix.com
Phone: (978) 921-4125
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Leo Ehrlich CPA (Age 66)
Chairman, CEO, CFO, Principal Accounting Officer & Secretary
Comp: $515.85k
Ms. Jane Harness M.S. (Age 56)
MP, Senior Vice President of Clinical Sciences & Portfolio Management
Comp: $275k
Mr. Jim Boeheim
Business Advisor

Key Competitors

View All Competitors

IPIX Stock Analysis - Frequently Asked Questions

How have IPIX shares performed in 2024?: Innovation Pharmaceuticals' stock was trading at $0.0049 at the beginning of 2024. Since then, IPIX shares have increased by 106.1% and is now trading at $0.0101.
View the best growth stocks for 2024 here.
Are investors shorting Innovation Pharmaceuticals?: Innovation Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 18,000 shares, a drop of 70.4% from the March 15th total of 60,900 shares. Based on an average trading volume of 584,300 shares, the days-to-cover ratio is currently 0.0 days.
View Innovation Pharmaceuticals' Short Interest.
What other stocks do shareholders of Innovation Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Innovation Pharmaceuticals investors own include Vaxart (VXRT), Broadcom (AVGO), Fulcrum Therapeutics (FULC), VIVUS (VVUS), CytoDyn (CYDY), ServiceNow (NOW), Sorrento Therapeutics (SRNE), United Airlines (UAL), Heat Biologics (HTBX) and Micron Technology (MU).
How do I buy shares of Innovation Pharmaceuticals?: Shares of IPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IPIX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Innovation Pharmaceuticals (IPIX) Stock Price, News & Analysis

About Innovation Pharmaceuticals Stock (OTCMKTS:IPIX)

IPIX Stock Price History

IPIX Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

IPIX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info